AI Prospecting for GE HealthCare Technologies
Company data:
Company size:
51000 employeesWebsite URL:
https://www.gehealthcare.comIndustry
Medical Devices & EquipmentHeadquarters:
Chicago, Illinois, USAInvestment round:
Publicly Traded (NASDAQ: GEHC)ARR:
$19 billionLatest news about GE HealthCare Technologies
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
GE HealthCare has invested $2.2 billion in R&D since 2022, focusing on AI, digital solutions, and advanced imaging technologies. At the 2024 Investor Day, they outlined plans for mid-single digit organic revenue growth, expansion in emerging markets, and significant AI-enabled innovations, including new products like CleaRecon DL and TrueFidelity DL[1][3][4].
GE HealthCare has announced a 510(k) submission for CleaRecon DL, an AI-based technology to improve image quality in interventional suites. They also unveiled new products at RSNA 2024, including the Vscan Air SL with Caption AI, Aurora dual head SPECT/CT, and True Enhance DL for CT exams[2][3]. Additionally, GE HealthCare is acquiring the remaining 50% stake in Nihon Medi-Physics, a leading radiopharmaceutical company in Japan[2].
GE HealthCare announced a 17% increase in its quarterly cash dividend and updated its medium-term financial framework, anticipating mid-single digit organic revenue growth and high-single to low-double digit adjusted EPS growth, during its 2024 Investor Day focused on innovation and precision care[3].
Open job positions at GE HealthCare Technologies
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.
